These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 26718207)

  • 21. Current treatment guidelines for acromegaly.
    Melmed S; Jackson I; Kleinberg D; Klibanski A
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2646-52. PubMed ID: 9709926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathology of acromegaly.
    Horvath E; Kovacs K
    Neuroendocrinology; 2006; 83(3-4):161-5. PubMed ID: 17047379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acromegaly].
    Chanson P
    Presse Med; 2009 Jan; 38(1):92-102. PubMed ID: 19004612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acromegaly: assessing the disorder and navigating therapeutic options for treatment.
    Melmed S; Kleinberg DL; Bonert V; Fleseriu M
    Endocr Pract; 2014 Oct; 20 Suppl 1():7-17; quiz 18-20. PubMed ID: 25374336
    [No Abstract]   [Full Text] [Related]  

  • 25. Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly.
    Silverstein JM
    Pituitary; 2016 Oct; 19(5):536-43. PubMed ID: 27405306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acromegaly and Cushing's disease: Persistence of comorbidities after the control of hypersecretion].
    Rochette C; Castinetti F; Brue T
    Ann Endocrinol (Paris); 2016 Oct; 77 Suppl 1():S19-S28. PubMed ID: 28645354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical assessment and long-term monitoring in patients with acromegaly: statement from a joint consensus conference of the Growth Hormone Research Society and the Pituitary Society.
    ;
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3099-102. PubMed ID: 15240576
    [No Abstract]   [Full Text] [Related]  

  • 28. [Recommendations of Neuroendocrinology Department from Brazilian Society of Endocrinology and Metabolism for diagnosis and treatment of acromegaly in Brazil].
    Vieira Neto L; Abucham J; Araujo LA; Boguszewski CL; Bronstein MD; Czepielewski M; Jallad RS; Musolino NR; Naves LA; Ribeiro-Oliveira Júnior A; Vilar L; Faria Mdos S; Gadelha MR
    Arq Bras Endocrinol Metabol; 2011 Mar; 55(2):91-105. PubMed ID: 21584426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Insulin resistance in pituitary, thyroid, and adrenal diseases].
    Iitaka M; Katayama S
    Nihon Rinsho; 2000 Feb; 58(2):451-5. PubMed ID: 10707575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline.
    Fleseriu M; Hashim IA; Karavitaki N; Melmed S; Murad MH; Salvatori R; Samuels MH
    J Clin Endocrinol Metab; 2016 Nov; 101(11):3888-3921. PubMed ID: 27736313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consensus statement: medical management of acromegaly.
    Melmed S; Casanueva F; Cavagnini F; Chanson P; Frohman LA; Gaillard R; Ghigo E; Ho K; Jaquet P; Kleinberg D; Lamberts S; Laws E; Lombardi G; Sheppard MC; Thorner M; Vance ML; Wass JA; Giustina A
    Eur J Endocrinol; 2005 Dec; 153(6):737-40. PubMed ID: 16322377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A consensus on criteria for cure of acromegaly.
    Giustina A; Chanson P; Bronstein MD; Klibanski A; Lamberts S; Casanueva FF; Trainer P; Ghigo E; Ho K; Melmed S;
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3141-8. PubMed ID: 20410227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO).
    Barosi G; Boccadoro M; Cavo M; Corradini P; Marchetti M; Massaia M; Merlini G; Tosi P; Tura S; ; ;
    Haematologica; 2004 Jun; 89(6):717-41. PubMed ID: 15194540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes in Cushing syndrome: basic and clinical aspects.
    Mazziotti G; Gazzaruso C; Giustina A
    Trends Endocrinol Metab; 2011 Dec; 22(12):499-506. PubMed ID: 21993190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Scleral rigidity in certain endocrinological diseases: III. Cushing's syndrome and disease and acromegaly (author's transl)].
    Czechowicz-Janicka K; Kłos J; Perkowicz-Szulczykowa J
    Klin Oczna; 1981 Jun; 83(6):289-91. PubMed ID: 7289418
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of endocrine disease: GH excess: diagnosis and medical therapy.
    Andersen M
    Eur J Endocrinol; 2014 Jan; 170(1):R31-41. PubMed ID: 24144967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological therapy for acromegaly: a critical review.
    Muller AF; Van Der Lely AJ
    Drugs; 2004; 64(16):1817-38. PubMed ID: 15301564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical Treatments for Acromegaly: A Systematic Review and Network Meta-Analysis.
    Leonart LP; Ferreira VL; Tonin FS; Fernandez-Llimos F; Pontarolo R
    Value Health; 2018 Jul; 21(7):874-880. PubMed ID: 30005760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
    Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.